news & event about long-acting interferon drug product company
Home / News / Company News / Amoytop Biotech is awarded “First Batch of National Intellectual Property Advantageous Enterprises”

Amoytop Biotech is awarded “First Batch of National Intellectual Property Advantageous Enterprises”

Views: 0     Author: Site Editor     Publish Time: 2013-12-18      Origin: Site

Inquire

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

       为贯彻落实《国家知识产权战略纲要》和《全国专利事业发展战略(2011-2020年)》精神,加快形成一批拥有自主知识产权和知名品牌、国际竞争力较强的骨干企业,根据《关于开展国家级知识产权优势企业和示范企业培育工作的通知》(国知发管字〔2013〕36号)要求,在有关部门和各地方的推荐下,经审核,厦门特宝生物工程股份有限公司被确定第一批国家级知识产权优势企业,期限自2013年12月至2015年11月。

RELATED NEWS

content is empty!

RELATED PRODUCTS

content is empty!

Facebook
Twitter
LinkedIn
Instagram

WELCOME

Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
Leave a Message
Get In Touch